A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer

Por Vistad, Ingvild, Cvancarova, Milada, Kristensen, Gunnar Balle, Fosså, Sophie Dorothea
Publicado em 2011

Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients

Por Fjeldbo, Christina S., Aarnes, Eva-Katrine, Malinen, Eirik, Kristensen, Gunnar B., Lyng, Heidi
Publicado no PLoS One (2016)

Human Papillomavirus DNA and E6/E7 mRNA Status in Relation to Survival of Patients Treated for Cervical Squamous Cell Carcinoma

Por Holm, Ruth, Kraus, Irene, Skomedal, Hanne, Langerød, Anita, Kristensen, Gunnar B, Lyng, Heidi
Publicado em 2008

Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis

Por Holm, Ruth, de Putte, Gregg Van, Suo, Zhenhe, Lie, A Kathrine, Kristensen, Gunnar B
Publicado em 2008

High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection

Por Andersen, Anders, Warren, David J, Brunsvig, Paal F, Aamdal, Steinar, Kristensen, Gunnar B, Olsen, Harald
Publicado em 2006

The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer

Por Nielsen, Birgitte, Albregtsen, Fritz, Kildal, Wanja, Abeler, Vera M., Kristensen, Gunnar B., Danielsen, Håvard E.
Publicado no Anal Cell Pathol (Amst) (2012)

Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas

Por Kraus, Irene, Molden, Tor, Holm, Ruth, Lie, A. Kathrine, Karlsen, Frank, Kristensen, Gunnar B., Skomedal, Hanne
Publicado em 2006

Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas

Por Dai, Haiyan, Holm, Ruth, Kristensen, Gunnar B., Abeler, Vera M., Børresen‐Dale, Anne‐Lise, Helland, Åslaug
Publicado no Anal Cell Pathol (2001)

L1CAM as a prognostic marker in stage I endometrial cancer: a validation study

Por Smogeli, Elisabeth, Davidson, Ben, Cvancarova, Milada, Holth, Arild, Katz, Betina, Risberg, Bjørn, Kristensen, Gunnar, Lindemann, Kristina
Publicado no BMC Cancer (2016)

Metabolic mapping by use of high-resolution magic angle spinning ¹H MR spectroscopy for assessment of apoptosis in cervical carcinomas

Por Sundfør Kolbein, Jensen Line R, Bathen Tone F, Sitter Beathe, Lyng Heidi, Kristensen Gunnar B, Gribbestad Ingrid S
Publicado em 2007-01-01

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

Por Kringen, Pedro, Wang, Yun, Dumeaux, Vanessa, Nesland, Jahn M, Kristensen, Gunnar, Borresen-Dale, Anne-Lise, Dorum, Anne
Publicado em 2005

Metabolic mapping by use of high-resolution magic angle spinning (1)H MR spectroscopy for assessment of apoptosis in cervical carcinomas

Por Lyng, Heidi, Sitter, Beathe, Bathen, Tone F, Jensen, Line R, Sundfør, Kolbein, Kristensen, Gunnar B, Gribbestad, Ingrid S
Publicado em 2007

Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients

Por Halvorsen, Ann Rita, Kristensen, Gunnar, Embleton, Andy, Adusei, Cybil, Barretina-Ginesta, Maria Pilar, Beale, Philip, Helland, Åslaug
Publicado no Dis Markers (2017)

DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium

Por Pradhan, Manohar, Davidson, Ben, Abeler, Vera Maria, Danielsen, Håvard Emil, Tropé, Claes Göran, Kristensen, Gunnar Balle, Risberg, Björn Åke
Publicado em 2012

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensiti...

Por Wang, Yun, Herrstedt, Jørn, Havsteen, Hanne, DePoint Christensen, Rene, Mirza, Mansoor Raza, Lund, Bente, Maenpaa, Johanna, Kristensen, Gunnar
Publicado no BMC Cancer (2014)

Entropy-Based Adaptive Nuclear Texture Features are Independent Prognostic Markers in a Total Population of Uterine Sarcomas

Por Nielsen, Birgitte, Hveem, Tarjei Sveinsgjerd, Kildal, Wanja, Abeler, Vera M, Kristensen, Gunnar B, Albregtsen, Fritz, Danielsen, Håvard E, Rohde, Gustavo K
Publicado no Cytometry A (2015)

Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer

Por Lyng, Heidi, Brøvig, Runar S, Svendsrud, Debbie H, Holm, Ruth, Kaalhus, Olav, Knutstad, Kjetil, Oksefjell, Halldis, Sundfør, Kolbein, Kristensen, Gunnar B, Stokke, Trond
Publicado em 2006

Gene Dosage, Expression, and Ontology Analysis Identifies Driver Genes in the Carcinogenesis and Chemoradioresistance of Cervical Cancer

Por Lando, Malin, Holden, Marit, Bergersen, Linn C., Svendsrud, Debbie H., Stokke, Trond, Sundfør, Kolbein, Glad, Ingrid K., Kristensen, Gunnar B., Lyng, Heidi
Publicado em 2009

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Por Lindemann, Kristina, Malander, Susanne, Christensen, Rene D, Mirza, Mansoor R, Kristensen, Gunnar B, Aavall-Lundqvist, Elisabeth, Vergote, Ignace, Rosenberg, Per, Boman, Karin, Nordstrøm, Britta
Publicado em 2014

Gene expression signatures of primary and metastatic uterine leiomyosarcoma

Por Davidson, Ben, Abeler, Vera Maria, Førsund, Mette, Holth, Arild, Yang, Yanqin, Kobayashi, Yusuke, Chen, Lily, Kristensen, Gunnar B., Shih, Ie-Ming, Wang, Tian-Li
Publicado em 2013